{
    "2018-12-14": [
        [
            {
                "time": "2018-12-14",
                "original_text": "沪深上市公司18年12月14日晚间上市公司重要公告",
                "features": {
                    "keywords": [
                        "沪深",
                        "上市公司",
                        "公告"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-14",
                "original_text": "今日（12月14日）沪深股通、港股通资金流向",
                "features": {
                    "keywords": [
                        "沪深股通",
                        "港股通",
                        "资金流向"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-14",
                "original_text": "12月14日上市公司晚间公告速递",
                "features": {
                    "keywords": [
                        "上市公司",
                        "公告",
                        "速递"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-14",
                "original_text": "恒瑞医药：注射用帕瑞昔布钠获药品注册批件",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "注射用帕瑞昔布钠",
                        "药品注册批件"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-14",
                "original_text": "285亿资金争夺20股：主力资金重点出击2股(名单)",
                "features": {
                    "keywords": [
                        "285亿资金",
                        "主力资金",
                        "重点出击",
                        "名单"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-14",
                "original_text": "4+7城市药品集中采购成利器 仿制药进入薄利多销期",
                "features": {
                    "keywords": [
                        "4+7城市",
                        "药品集中采购",
                        "仿制药",
                        "薄利多销"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-12-14",
                "original_text": "医药生物行业周报:仿制药迎变局,把握确定性投资机会",
                "features": {
                    "keywords": [
                        "医药生物",
                        "仿制药",
                        "变局",
                        "投资机会"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}